![](/img/cover-not-exists.png)
Imatinib mesylate (Gleevec, STI-571) suppresses cytokine production by normal T-cells activated through T-cell receptor (TCR) signaling
Gao, H., Lee, B., Donato, N.J., Talpaz, M., Reuben, J.M.Volume:
115
Language:
english
Journal:
Journal of Allergy and Clinical Immunology
DOI:
10.1016/j.jaci.2004.12.893
Date:
February, 2005
File:
PDF, 36 KB
english, 2005